针对前列腺特异性膜抗原针对前列腺癌的产药
Christos Liolios1, George Laros1, Kyriakos Georgiou1
1Laboratory of Medicinal Chemistry, Section of Pharmaceutical Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens (NKUA), Panepistimiopolis-Zografou, 15771 Athens, Greece.
Journal of medicinal chemistry
|June 12, 2025
概括
向前列腺特异性膜抗原 (PSMA) 的干向药物 (LTD) 对转移性割耐药前列腺癌显示有前途. 这些针对PSMA的LTD直接向癌细胞输送细胞毒剂,性能优于传统化疗.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 前列腺特异性膜抗原 (PSMA),也称为谷氨酸碳素酶II (GCPII),在前列腺癌细胞中高度表达.
- 由于PSMA的特定表达特征,它成为癌症治疗的有吸引力的目标.
- 干向药物 (LTD) 提供了一种策略,可以将细胞毒剂专门向表达PSMA的瘤输送.
研究的目的:
- 审查针对PSMA的有限公司的结构和临床前数据.
- 讨论前列腺癌治疗中有希望的PSMA向性LTD的临床进展.
主要方法:
- 对针对PSMA的有限公司现有文献的审查.
- 对临床前体外和体内研究结果的分析.
- 对选择的针对PSMA的有限责任公司的可用临床试验数据的评估.
主要成果:
- 针对PSMA的LTD显示出对前列腺癌细胞的高度亲和力和特异性.
- 临床前研究表明,这些向性药物的有效性有希望.
- 几家针对PSMA的有限公司正在通过临床试验并取得令人鼓舞的结果.
结论:
- 针对PSMA的LTD代表了转移性割抵抗性前列腺癌治疗的重大进展.
- 与传统的细胞毒药物相比,这些向疗法有可能提高疗效并降低全身毒性.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.0K
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
相关概念视频
Prodrugs
2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
